Começar
AlenCiken

FDA lifts partial hold on Mersana cancer drug trial, but shares

Mersana Therapeutics, Inc. (NASDAQ:MRSN)  
AlenCiken  
NASDAQ:MRSN   Mersana Therapeutics, Inc.
Trend Analysis Chart Patterns Technical Indicators
0
0
trendanalysis chartpattern indicator
Shares of Cambridge-based Mersana Therapeutics Inc. plunged Monday despite announcing that the FDA would allow it to fully restart a cancer drug trial that was paused in July after one patient died.

www.bizjournals.com/...ana-cancer-drug.html
globenewswire.com/ne...ld-for-XMT-1522.html
Aviso legal

As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.